Article: Multisystem Inflammatory Syndrome after Ad26.COV2.S vaccination.
2022 Volume 27, Page(s) e01411
Abstract: ... with Ad26. COV2. S vaccine (Johnson &Johnson/Janssen), a recombinant adenovirus serotype 26 vector encoding ...
Abstract | Background: The multisystem inflammatory syndrome (MIS) is a rare and sometime life-threatening post-infectious complication of coronavirus disease 2019 (Covid-19) in children and adults. To date, only a very few reports have associated such systemic reaction with SARS-CoV-2 vaccination. Case report: we describe a case that resembled MIS, in a 46-year-old White man, 12 days after vaccination with Ad26. COV2. S vaccine (Johnson &Johnson/Janssen), a recombinant adenovirus serotype 26 vector encoding the SARS-CoV-2 spike glycoprotein. The patient experienced high grade fever, cutaneous rash, severe weakness, pericardial effusion and raised inflammatory markers, which met the criteria for definition of MIS. The symptoms improved with steroidal therapy. Conclusions: Our case suggests that MIS could occur after SARS-CoV-2 vaccination. |
---|---|
Language | English |
Publishing date | 2022-01-21 |
Publishing country | Netherlands |
Document type | Case Reports |
ZDB-ID | 2745454-X |
ISSN | 2214-2509 |
ISSN | 2214-2509 |
DOI | 10.1016/j.idcr.2022.e01411 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.